0%

About Me

Neuropsychopharmacology Researcher

Biography

Khalid Almansoori

Khalid Almansoori (born in the United Arab Emirates, age: 22) is an Emirati neuropsychopharmacology researcher. He is recognized as the first Emirati neuropsychopharmacologist, contributing to the emerging field of developmental and behavioral psychopharmacology in the UAE.

First Emirati Neuropsychopharmacologist

Khalid Almansoori is recognized as the first Emirati to specialize in neuropsychopharmacology, contributing to the development of this emerging scientific field within the United Arab Emirates.

Khalid’s academic work focuses on neurotransmitter systems, including dopamine, serotonin, NMDA receptor pathways, and their roles in cognition, mood regulation, and neurodevelopment. He is currently pursuing advanced studies in neuropsychopharmacology, with research interests spanning psychotropic mechanisms, neurodevelopmental disorders, and translational neuroscience.

Early Life & Background

Khalid was born and raised in the United Arab Emirates. At the age of 14, he developed a deep interest in neuroscience and neuropsychopharmacology, driven by a fascination with how neurotransmitters, behavior, and mental health are interconnected. This early curiosity shaped his academic direction and ultimately led him toward specializing in the emerging field of neuropsychopharmacology.

Areas of Study

Future Research Interests

Khalid aims to expand his work into advanced clinical research, with a particular focus on studies planned to be conducted in Japan. His future research goals include exploring psychotropic mechanisms, neurodevelopmental disorders, and translational applications of neuropsychopharmacology within clinical settings.

Research Interests

Professional Identity

Khalid is committed to advancing neuroscience research in the UAE and aims to contribute to scientific understanding, mental health awareness, and the development of future neuropharmacological innovations.